Determining Failure After Renal Ablative Therapy for Renal Cell Carcinoma: False-negative and False-positive Imaging Findings

Urology

Volumn 75, Issue 6, 2010, Pages 1254-1257

  Matin, Surena F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; INTERMETHOD COMPARISON; KIDNEY BIOPSY; KIDNEY CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RELIABILITY; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE;

BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; CATHETER ABLATION; COHORT STUDIES; CRYOSURGERY; DIAGNOSTIC IMAGING; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; POSTOPERATIVE CARE; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 77952744534     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.01.006     Document Type: Article

References (26)

1. Kummerlin I., ten Kate F., Smedts F., et al. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur Urol 53 (2008) 1219-1225
2. Zagoria R.J., Traver M.A., Werle D.M., et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189 (2007) 429-436
3. Lebret T., Poulain J.E., Molinie V., et al. Percutaneous core biopsy for renal masses: indications, accuracy, and results. J Urol 178 (2007) 1184-1188
4. Volpe A., Kachura J.R., Geddie W.R., et al. Techniques, safety, and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 178 (2007) 379-386
5. Skinnider B.F., Folpe A.L., Hennigar R.A., et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 29 (2005) 747-754
6. Liu L., Qian J., Singh H., et al. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 131 (2007) 1290-1297
7. American Urological Association. Guideline for management of the clinical stage 1 renal mass. http://www.auanet.org Accessed September 3, 2009
8. Matsumoto E.D., Watumull L., Johnson D.B., et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol 172 (2004) 45-48
9. Remer E.M., Weinberg E.J., Oto A., et al. MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol 174 (2000) 635-640
10. Svatek R.S., Sims R., Anderson J.K., et al. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology 67 (2006) 508-512
11. Anderson J.K., Shingleton W.B., and Cadeddu J.A. Imaging associated with percutaneous and intraoperative management of renal tumors. Urol Clin North Am 33 (2006) 339-352
12. Matin S.F., Ahrar K., Cadeddu J.A., et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 176 (2006) 1973-1977
13. Israel G.M., and Bosniak M.A. How I do it: evaluating renal masses. Radiology 236 (2005) 441-450
14. Israel G.M., and Bosniak M.A. Pitfalls in renal mass evaluation and how to avoid them. Radiographics 28 (2008) 1325-1338
15. Hecht E.M., Israel G.M., Krinsky G.A., et al. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 232 (2004) 373-378
16. Weight C.J., Kaouk J.H., Hegarty N.J., et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 179 (2008) 1277-1281 discussion 1281-1283
17. Raman J.D., Stern J.M., Zeltser I., et al. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol 179 (2008) 2142-2145
18. Javadi S., Matin S.F., Tamboli P., et al. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol 18 (2007) 1186-1191
19. Lokken R.P., Gervais D.A., Arellano R.S., et al. Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol 189 (2007) 845-848
20. Lin C.H., Moinzadeh A., Ramani A.P., et al. Histopathologic confirmation of complete cancer-cell kill in excised specimens after renal cryotherapy. Urology 64 (2004) 590
21. Matlaga B.R., Zagoria R.J., Woodruff R.D., et al. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 168 (2002) 2401-2405 comment 2409-2410
22. Michaels M.J., Rhee H.K., Mourtzinos A.P., et al. Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 168 (2002) 2406-2410
23. Rendon R.A., Kachura J.R., Sweet J.M., et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 167 (2002) 1587-1592
24. Zlotta A.R., Wildschutz T., Raviv G., et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 11 (1997) 251-258
25. Klingler H.C., Marberger M., Mauermann J., et al. "Skipping" is still a problem with radiofrequency ablation of small renal tumors. BJU Int 99 (2007) 998-1001
26. Hsu T.H., Fidler M.E., and Gill I.S. Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology 56 (2000) 872-875